Wanbury Limited (WANBURY)

293.46

INR
-12.29(-4.02%)
As of December 13, 2024 9:59:00 AM

Wanbury Limited Share Price Information

24 hour Low and High

Low: 293.46
High: 293.46

All time High

321.85

Price Change 1h

+₹-12.29 +-4.02%

Price Change 1d

+₹-12.29 +-4.02%

Price Change 1w

+₹64.20 +28.00%

Wanbury Limited Market Information

Exchange

NSE

Market Cap

₹746.78 Cr

About Wanbury Limited Share

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pradeep Patni

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Wanbury Limited's (NSE:WANBURY) Price Is Right But Growth Is Lacking After Shares Rocket 26%
  • Wanbury surges 5% after USFDA issues Zero observations for Patalganga site
  • Wanbury Shares Hit 5% Upper Circuit on API Pipeline and Launches
  • Wanbury Ltd. Reports 696% Increase in Net Profit for Q4FY24
  • Wanbury gains 5% on conclusion of USFDA inspection at Maharashtra unit with zero observation

FAQs

Wanbury Limited (WANBURY)

293.46

INR
-12.29(-4.02%)
As of December 13, 2024 9:59:00 AM

Wanbury Limited Share Price Information

24 hour Low and High

Low: 293.46
High: 293.46

All time High

321.85

Price Change 1h

+₹-12.29 +-4.02%

Price Change 1d

+₹-12.29 +-4.02%

Price Change 1w

+₹64.20 +28.00%

Wanbury Limited Market Information

Exchange

NSE

Market Cap

₹746.78 Cr

About Wanbury Limited Share

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pradeep Patni

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Wanbury Limited's (NSE:WANBURY) Price Is Right But Growth Is Lacking After Shares Rocket 26%
  • Wanbury surges 5% after USFDA issues Zero observations for Patalganga site
  • Wanbury Shares Hit 5% Upper Circuit on API Pipeline and Launches
  • Wanbury Ltd. Reports 696% Increase in Net Profit for Q4FY24
  • Wanbury gains 5% on conclusion of USFDA inspection at Maharashtra unit with zero observation

FAQs